Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kalafatis

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Biochemistry|August 26, 1998
Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa bindingR M Camire, M Kalafatis, P B Tracy
The Journal of Biological Chemistry|December 16, 1994
The mechanism of inactivation of human factor V and human factor Va by activated protein CM Kalafatis, M D Rand, K G Mann
Protein Science : a Publication of the Protein Society|September 23, 1997
The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein SJ O Egan, M Kalafatis, K G Mann
The Journal of Biological Chemistry|December 15, 1990
Identification and characterization of a phospholipid-binding site of bovine factor VaM Kalafatis, R J Jenny, K G Mann
Biochemistry|January 18, 1994
Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactorM Kalafatis, M D Rand, K G Mann
Blood|April 15, 1994
Platelet coagulation factor Va: the major secretory platelet phosphoproteinM D Rand, M Kalafatis, K G Mann
Journal of Thrombosis and Haemostasis : JTH|October 25, 2006
Peptidomimetic inhibitors for activated protein C: implications for hemophilia managementS Butenas, T Orfeo, M Kalafatis, et al.
Blood|November 1, 1987
Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1,365M Kalafatis, Y Takahashi, J P Girma, et al.
The Journal of Biological Chemistry|September 20, 1996
An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeidenL Bajzar, M Kalafatis, P Simioni, et al.
Thrombosis and Haemostasis|December 22, 1988
Abnormality of the N-terminal portion of von Willebrand factor in type IIA and IIC von Willebrand diseaseY Takahashi, M Kalafatis, J P Girma, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Biochemistry|August 26, 1998
Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa bindingR M Camire, M Kalafatis, P B Tracy
The Journal of Biological Chemistry|December 16, 1994
The mechanism of inactivation of human factor V and human factor Va by activated protein CM Kalafatis, M D Rand, K G Mann
Protein Science : a Publication of the Protein Society|September 23, 1997
The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein SJ O Egan, M Kalafatis, K G Mann
The Journal of Biological Chemistry|December 15, 1990
Identification and characterization of a phospholipid-binding site of bovine factor VaM Kalafatis, R J Jenny, K G Mann
Biochemistry|January 18, 1994
Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactorM Kalafatis, M D Rand, K G Mann
Blood|April 15, 1994
Platelet coagulation factor Va: the major secretory platelet phosphoproteinM D Rand, M Kalafatis, K G Mann
Journal of Thrombosis and Haemostasis : JTH|October 25, 2006
Peptidomimetic inhibitors for activated protein C: implications for hemophilia managementS Butenas, T Orfeo, M Kalafatis, et al.
Blood|November 1, 1987
Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1,365M Kalafatis, Y Takahashi, J P Girma, et al.
The Journal of Biological Chemistry|September 20, 1996
An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeidenL Bajzar, M Kalafatis, P Simioni, et al.
Thrombosis and Haemostasis|December 22, 1988
Abnormality of the N-terminal portion of von Willebrand factor in type IIA and IIC von Willebrand diseaseY Takahashi, M Kalafatis, J P Girma, et al.
Pageof 6